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AN INVESTIGATION OF WILLINGNESS TO BUY GENERIC 
PRESCRIPTION MEDICINES IN AUSTRALIA 
 
ABSTRACT 
This paper investigates consumer perception on prescription generic medicines 
(PGM) in Australia. Specifically, it examines how consumer concern and consumer 
knowledge about counterfeit medicines influence attitudes towards generic 
prescription medicine and willingness to pay more for branded prescription 
medicines. Data were collected using mail surveys to reach mature age population and 
281 usable responses were used for analysis. The consumer concern was found to be 
significant predictor of attitude and willingness to pay more for branded prescription 
medicines but consumer knowledge is an insignificant predictor. Implications of the 
study and the corresponding recommendations are presented and discussed. 
 
INTRODUCTION 
The World Health Organization (WHO) estimates that up to 60% of drugs in some 
developing countries and up to 20% in some developed countries are counterfeits 
(Liang, 2006; WHO, 2010). More than 50 percent of medicines that purchased from 
Internet are counterfeit and some researchers suggest that currently 60 percent of 
online products are counterfeit or substandard (Howard, 2010). While there are many 
studies done in this area (e.g. Moken, 2003; Liang, 2006; Lybecker, 2007), there is a 
dearth of research from the consumers perspective (Bian and Veloutsou, 2007; 
Staake, Thiesse, and Fleisch, 2009; Veloutsou and Bian, 2008). There are two 
overarching issues with respect to counterfeit drugs globally. First, consumers 
“unknowingly” purchase deceptive counterfeit drugs (Bloch et al., 1993; Liang, 
2006). These can be defined as drugs sold as pharmaceutical company brand name 
drugs, usually at a much lower price. These drugs may (a) contain a lesser amount of 
the real drug’s active ingredient (b) contain no active ingredient at all (c) compose of 
substances varying from talcum power to aspirin to poison (d) blatantly mimic the 
real drug, inclusive of the manufacturer’s labels, pamphlets, and purity seals but are in 
fact fakes (Moken, 2003). Second, consumers are confused if “generic brands” of 
drugs are in fact counterfeits (d’Astous and Gargouri, 2001; Lybecker, 2008). As 
such, the growing consumer concern and the lack of consumer knowledge have led to 
less than favourable attitudes towards counterfeiting (Bang et al., 2000; Liang, 2006; 
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Marcketti and Shelley, 2009).. In the context of this study, consumers in Australia 
also have the same issues with respect to counterfeit medicines as well.  
 
LITERATURE REVIEW AND HYPOTHESES DEVELOPMENT 
To begin with, most generic medicine literatures only focus on general practitioners 
or pharmacists perception (Hassali, Kong, and Stewart, 2006; Hassali, Shafie, and 
Awaisu, 2010) but little research has done in consumer perception. Specifically, there 
is no study of consumer perspective in Australia about generic medicine. This gap can 
be considered to be done in this study to understand more consumer perception in 
generic medicine in Australia. Consumers have confused about the difference 
between generic medicine and counterfeit medicine that lead consumer willingly to 
pay more for genuine medicine in the market (d’Astous and Gargouri, 2001; 
Lybecker, 2008). Most of consumer perception studies about generic medicines are 
done in qualitative studies (Sharrad and Hassali, 2010; Chua, Hassali, Shafie, and 
Awaisu 2010). Therefore, empirical study will be considered in this study to analyze 
consumer perception by using research model to explain the causal relationship 
among all variables in the research model.  
Consumer concern - When consumers believe that there is a certain problem and 
they are concerned, they are more likely to adopt to consumer behaviour practices to 
assuage or solve the problem (Hines et al., 1986; Marcketti and Shelley, 2009). It was 
found that the greater the knowledge and concern about issues within the industry, it 
was related to greater support for more socially responsible businesses (Dickson, 
2000). Consumer concern in the counterfeiting context examines consumer concerns 
regarding labelling, the legitimateness of the supplier, the source of drug production, 
the country of origin, contamination of drugs, cost, penalties of being caught 
possessing counterfeit drugs, health risks, drug policy and regulations and effects of 
purchasing counterfeit prescription medicines (Moken, 2003; Liang, 2006). Therefore, 
it can be proposed that; 
H1a: Consumer concern about counterfeit medicine has a positive influence on the 
attitude towards generic prescription medicine. 
H1b: Consumer concern about counterfeit medicine has a positive influence on the 
willingness to pay more for trade name (branded) prescription medicines. 
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Consumer Knowledge - The term is the cognitive representation of product-related 
experience in a consumer’s memory, which takes the form of a product schema and is 
likely to contain knowledge in the form of coded representations of brands, product 
attributes, usage situations, general product class information, and evaluation and 
choice rules (Maheswaran, 1994; Marcketti and Shelley, 2009). Farhar (1996) states 
that consumer perceptions and preferences about the environment are influenced by 
both factual and faulty information. If consumers are more knowledgeable, they will 
have information that would better assist them in making their decisions. More 
knowledgeable consumers are also more willing to pay a higher price (Bang et al., 
2000). In the context of TRA, it makes sense that heightened knowledge about 
counterfeit medicine would lead to stronger beliefs about the positive consequence or 
benefits of generic prescription medicine. 
 
H2a: There is a positive relationship between consumer knowledge about counterfeit 
medicines and attitude towards generic prescription medicines. 
H2b: There is a positive relationship between consumer knowledge about counterfeit 
medicines and willingness to pay more for trade name (branded) prescription 
medicines. 
 
Attitudes towards generic prescription medicines (GPM) - Attitude towards the 
behaviour is stronger than attitudes towards an object as it will result in higher 
likelihood of purchasing. Attitudes are beliefs and perceptions of consumers. Some of 
the common beliefs and concerns about GPM are the quality and functionality 
aspects, the social consequences, and the legality of generic prescription medicines. 
The TRA proposes that attitudes towards a behavior are influenced by beliefs that the 
behavior leads to significant consequences. In this context of study, consumers with 
strong concern of positive consequence to not purchase counterfeit medicines were 
significantly more likely to indicate they would be willing to pay more to purchase 
trade name (branded) medicines (Bang et al., 2000). 
H3: There is a positive relationship between attitudes towards generic prescription 
medicines and willingness to pay more for trade name (branded) prescription 
medicines. 
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Willingness to pay more for branded prescription medicines - The more that the 
consumer knows about the advantages of branded prescription medicines, they are 
more likely to pay more for it (Bang et al., 2000).  The willingness to pay more is a 
relevant measure and reflects the attitude towards the behaviour of consuming generic 
prescription medicines. If consumers have stronger beliefs about the positive 
consequences of purchasing genuine prescription medicines, they will have a higher 
willingness to pay more for the genuine prescription medicines. Higher willingness to 
pay more for genuine prescription medicines will also lead to higher likelihood to not 
purchase generic prescription medicines from a legitimate drug store or from the 
Internet.  
 
H4a: Willingness to pay more for trade name prescription medicines has a positive 
influence to the likelihood to not purchase generic prescription medicines from a 
legitimate drug store. 
H4b: Willingness to pay more for trade name (branded) prescription medicines has a 
positive influence to the likelihood to not purchase generic prescription medicines 
from the Internet. 
 
Consumer trust in internet shopping - Trust can be defined as a set of specific 
relationship intention dealing primarily with integrity, benevolence, competence, and 
predictability of an Internet online retailer (Gefen, Karahanna, and Straub, 2003). 
Previous studies have shown that consumer generally will avoid shopping online if 
the online retailers cannot be trusted (Gefen, 2000; Jarvenpaa and Tractinsky, 1999). 
There is no study about consumer trust to purchase GPM in internet shopping that 
moderate willingness to pay more for trade name (branded) prescription medicines 
and the likelihood to not purchase generic prescription medicines from the Internet. 
 
H5: Consumer trusts in internet shopping is a moderation variable between 
willingness to pay more for purchase genuine prescription medicines and the 
likelihood for a consumer not to purchase generic prescription medicines from the 
Internet. 
 
METHODOLOGY 
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A mail survey through systematic sampling from the white pages was used to capture 
the targeted sample population of consumers in Australia nationwide who consume or 
purchase generic prescription medicines, hence achieving ecological validity (Cowan, 
1989; Hornik and Ellis, 1988). The survey form consists of a number of sections 
comprising establishing scales on consumer concern, consumer knowledge, attitude 
towards PGM, willingness to pay more for branded prescription medicine, consumer 
trust in internet shopping, and likelihood to purchase branded prescription medicines 
from legitimate or drug store (from Marcketti and Shelley, 2009; Wang et al., 2005; 
Cheung and Lee, 2001). All items were measured on a seven-point Likert scale. 281 
usable responses (12.8% response rate) were used in the analysis. The sample 
consisted of slightly more males (51.2%) than females. The majority of respondents 
were aged 46 and above (68.3%) and 71.5 percent of respondents are medicine users. 
 
RESULT AND ANALYSIS 
An exploratory factor analysis was conducted on all variables in the study and it 
shows that there is no overlapping among all variables except attitude towards PGM. 
Therefore, factor analysis was conducted again on the original 8-items “Attitudes 
towards generic prescription medicines” scale to found out the 2 dimension factors. 
Two factors emerged from Varimax rotation and were named “social consequence” 
and “subjective judgement”. For subsequent SEM analysis to be valid, the 
measurement model (CFA) must be estimated first. The results of CFA estimation has 
shown that all items are loaded significantly (P<0.001) on each factor. All direct 
effect estimates are positive. Most squared multiple correlations are at least 0.30. 
These measurement model results establish divergent validity of the underlying 
constructs and establish an essential pre-condition for the validity of subsequent 
structural model estimation. Structural Equation Modelling (SEM) was conducted to 
test the model fit for the research model. After some adjustments to the model, the 
model (Figure 1) can be considered as good model fit (χ² (57) = 123.346, p = .000, 
CMIN/df= 2.164), other indicators such as RMSEA = .064, GFI = .938, AGFI = .901, 
TLI = .966 and CFI = .975 are within the recommended fit level. From SEM result, 
hypothesis 1b and 4a are accepted. Conversely, hypothesis 1a, 2a, 2b, 3, 4b, and 5 are 
rejected. 
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Multi group analysis (moderation test) was conducted to test the difference between 
two groups (“under 56” (N=148) vs “56 and above”(N=133)) in the model. The 
general model for moderation test is a good fit (χ² = 184.6, df = 92, p = .000, RMSEA 
= 0.060, GFI = 0.903, TLI = 0.951, CFI = 0.966). The constrained model with all the 
three regression weights restricted as being equal across the two groups also seemed 
to provide a good fit to the data (χ² = 277.898, df = 97, p = .000, RMSEA = 0.076, 
TLI = 0.910, and CFI = 0.934 are in recommended level of fit (Hu and Bentler, 
1999)). The Δχ² is 93.3 which is significantly higher than critical value at .05 level 
(Critical value = 11.07). Therefore, age group (“Under 56” vs “56 and above”) is a 
significant moderator. The results show there is no significant moderating effect of 
“under 56” vs “56 and above” on the link between concern and attitude, attitude and 
willingness, and concern and willingness. Hence, “under 56” vs “56 and above” does 
not appear to moderate those relationship between concern, attitude and attitude and 
willingness, and concern and willingness. 
 
Multi group analysis (moderation test) was conducted to test the difference between 
“medicine users” (N= 201) and “non medicine users” (N= 80) in the model. The 
general model for mediation test is a good fit (χ² = 187.738, df = 92, p = .000, 
RMSEA = 0.062, GFI = 0.903, TLI = 0.948, and CFI = 0.964). The constrained 
model with all the three regression weights restricted as being equal across the two 
groups also seemed to provide a good fit to the data (χ² = 287.913, df = 97, p = .000, 
RMSEA = 0.078, TLI = 0.904, and CFI = 0.930 (Hu and Bentler, 1999). The Δχ²is 
100.2 which is significantly higher than critical value at .05 level (Critical value = 
11.07). Therefore, users vs non-users is a significant moderator. Based on the results, 
users vs non-users appears to moderate those relationship between concern and 
attitude and attitude and willingness but not the link between concern and willingness. 
Mediation test was conducted to test the relationship between concern (IV) and 
willingness (DV), concern (IV) and attitude (MV), and attitude (MV) – willingness 
(DV) which  are all significant. The fit measures for the structural model showed 
satisfactory values (χ² = 116.235, df = 46, p = .000, RMSEA = 0.074, GFI = 0.937, 
TLI = 0.962 and CFI = 0.973) (Hu and Bentler, 1999). The Δχ² (before and after 
mediating effect) is 49.8 which is significantly higher than critical value at .05 level 
(Critical value = 27.59). Therefore, it can be argued that the condition for mediation is 
supported. The direct effects between concern and willingness (β = .433, p<.01) still 
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have significant result (β = .378, p<.01) after the mediating variables are included in 
the model, thus lending support to partial mediation effects. 
 
DISCUSSION AND IMPLICATION 
The results show that consumer concern about counterfeit medicines has negative 
influence with attitude towards PGM but positive influence with willingness to pay 
more for branded prescription medicines. Therefore, marketing and business 
practitioners must reduce consumer concern by giving education (i.e. education 
campaign or online learning service) to consumers about the difference between 
generic medicines and counterfeit medicines. The policy makers also need to ensure 
the regulatory system for prescription medicines especially generic medicines can be 
trusted for safety reason and maintain the quality standard. 
Further, findings also show that attitude towards PGM has negative influence with 
willingness to pay more for branded prescription medicines. Therefore, generic 
medicine industry should maintain their good image when consumers have trust to 
purchase their generic products and increase awareness of generic products to new 
target consumers by using education advertising through media. 
Another finding shows that willingness to pay more for trade name (branded) 
prescription medicines has a positive influence to the likelihood to not purchase 
generic prescription medicines from a legitimate drug store. Therefore, government 
and business practitioners should consider selling generic and branded medicines in 
legitimate drug store as consumers feel safer to purchase it rather than from the 
Internet shopping 
The findings from moderation test indicates that business practitioners should target 
non-users group and “under 56” group as their new target market by using education 
advertising or education campaign to reduce their concern about counterfeit 
medicines and know the difference between generic medicines and counterfeit 
medicines. 
The result from mediation test shows that government and business practitioners 
should reduce consumers concern about coun1terfeit medicines to attract them to 
purchase generic prescription medicines by implementing education campaign in the 
public to increase consumer awareness in generic medicine. 
 
CONCLUDING COMMENTS 
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It was found that consumer concern is a strong predictor of attitude towards PGM and 
willingness to pay more for branded prescription medicines. Other future directions 
can include a cross cultural comparison between a developed and developing country 
as to whether there are varying levels of knowledge and concern about counterfeit 
medicines. The sample size for this study can also be  expanded to provide different 
demographic groups. 
 
Figure 1: Final SEM Model  
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